Global Digital Pathology Services 麻豆原创 Growth (Status and Outlook) 2024-2030

Publication ID:

LPI11246203

Publication Date:

November 13, 2024

Pages:

134

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Digital Pathology Services involve the use of digital imaging technology to scan, analyze, and manage pathology slides, transforming traditional microscopic examination into a digitized, automated, and more accessible process. These services are revolutionizing the field of pathology by enhancing the efficiency, accuracy, and collaboration in the diagnosis and study of diseases.
The global Digital Pathology Services market size is projected to grow from US$ 3655 million in 2024 to US$ 5880 million in 2030; it is expected to grow at a CAGR of 8.2% from 2024 to 2030.
LPI (publisher)' newest research report, the 鈥淒igital Pathology Services Industry Forecast鈥� looks at past sales and reviews total world Digital Pathology Services sales in 2022, providing a comprehensive analysis by region and market sector of projected Digital Pathology Services sales for 2023 through 2029. With Digital Pathology Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Digital Pathology Services industry.
This Insight Report provides a comprehensive analysis of the global Digital Pathology Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Digital Pathology Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Digital Pathology Services market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Digital Pathology Services and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Digital Pathology Services.
United States market for Digital Pathology Services is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Digital Pathology Services is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Digital Pathology Services is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Digital Pathology Services players cover Inotiv, Charles River Laboratories, Leica Biosystems, Olympus, Philips, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Digital Pathology Services market by product type, application, key players and key regions and countries.
Segmentation by Type:
Cytopathology
Histopathology
Other
Segmentation by Application:
Hospital
Diagnostic Centers
Laboratories & Research Institutes
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Segmentation by Type:
Cytopathology
Histopathology
Other
Segmentation by Application:
Hospital
Diagnostic Centers
Laboratories & Research Institutes
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Inotiv
Charles River Laboratories
Leica Biosystems
Olympus
Philips
Roche
Hamamatsu Photonics
ZEISS
OptraScan
Media Cyber鈥嬧€媙etics
Visiopharm
Sectra
Digital Slide Archive
Aiforia
PathAI
Pathomation
Proscia
Indica Labs
Gestalt

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Digital Pathology Services 麻豆原创 Size 2019-2030
2.1.2 Digital Pathology Services 麻豆原创 Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Digital Pathology Services by Country/Region, 2019, 2023 & 2030
2.2 Digital Pathology Services Segment by Type
2.2.1 Cytopathology
2.2.2 Histopathology
2.2.3 Other
2.3 Digital Pathology Services 麻豆原创 Size by Type
2.3.1 Digital Pathology Services 麻豆原创 Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Digital Pathology Services 麻豆原创 Size 麻豆原创 Share by Type (2019-2024)
2.4 Digital Pathology Services Segment by Application
2.4.1 Hospital
2.4.2 Diagnostic Centers
2.4.3 Laboratories & Research Institutes
2.5 Digital Pathology Services 麻豆原创 Size by Application
2.5.1 Digital Pathology Services 麻豆原创 Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Digital Pathology Services 麻豆原创 Size 麻豆原创 Share by Application (2019-2024)
3 Digital Pathology Services 麻豆原创 Size by Player
3.1 Digital Pathology Services 麻豆原创 Size 麻豆原创 Share by Player
3.1.1 Global Digital Pathology Services Revenue by Player (2019-2024)
3.1.2 Global Digital Pathology Services Revenue 麻豆原创 Share by Player (2019-2024)
3.2 Global Digital Pathology Services Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Digital Pathology Services by Region
4.1 Digital Pathology Services 麻豆原创 Size by Region (2019-2024)
4.2 Global Digital Pathology Services Annual Revenue by Country/Region (2019-2024)
4.3 Americas Digital Pathology Services 麻豆原创 Size Growth (2019-2024)
4.4 APAC Digital Pathology Services 麻豆原创 Size Growth (2019-2024)
4.5 Europe Digital Pathology Services 麻豆原创 Size Growth (2019-2024)
4.6 Middle East & Africa Digital Pathology Services 麻豆原创 Size Growth (2019-2024)
5 Americas
5.1 Americas Digital Pathology Services 麻豆原创 Size by Country (2019-2024)
5.2 Americas Digital Pathology Services 麻豆原创 Size by Type (2019-2024)
5.3 Americas Digital Pathology Services 麻豆原创 Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Digital Pathology Services 麻豆原创 Size by Region (2019-2024)
6.2 APAC Digital Pathology Services 麻豆原创 Size by Type (2019-2024)
6.3 APAC Digital Pathology Services 麻豆原创 Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Digital Pathology Services 麻豆原创 Size by Country (2019-2024)
7.2 Europe Digital Pathology Services 麻豆原创 Size by Type (2019-2024)
7.3 Europe Digital Pathology Services 麻豆原创 Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Digital Pathology Services by Region (2019-2024)
8.2 Middle East & Africa Digital Pathology Services 麻豆原创 Size by Type (2019-2024)
8.3 Middle East & Africa Digital Pathology Services 麻豆原创 Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Digital Pathology Services 麻豆原创 Forecast
10.1 Global Digital Pathology Services Forecast by Region (2025-2030)
10.1.1 Global Digital Pathology Services Forecast by Region (2025-2030)
10.1.2 Americas Digital Pathology Services Forecast
10.1.3 APAC Digital Pathology Services Forecast
10.1.4 Europe Digital Pathology Services Forecast
10.1.5 Middle East & Africa Digital Pathology Services Forecast
10.2 Americas Digital Pathology Services Forecast by Country (2025-2030)
10.2.1 United States 麻豆原创 Digital Pathology Services Forecast
10.2.2 Canada 麻豆原创 Digital Pathology Services Forecast
10.2.3 Mexico 麻豆原创 Digital Pathology Services Forecast
10.2.4 Brazil 麻豆原创 Digital Pathology Services Forecast
10.3 APAC Digital Pathology Services Forecast by Region (2025-2030)
10.3.1 China Digital Pathology Services 麻豆原创 Forecast
10.3.2 Japan 麻豆原创 Digital Pathology Services Forecast
10.3.3 Korea 麻豆原创 Digital Pathology Services Forecast
10.3.4 Southeast Asia 麻豆原创 Digital Pathology Services Forecast
10.3.5 India 麻豆原创 Digital Pathology Services Forecast
10.3.6 Australia 麻豆原创 Digital Pathology Services Forecast
10.4 Europe Digital Pathology Services Forecast by Country (2025-2030)
10.4.1 Germany 麻豆原创 Digital Pathology Services Forecast
10.4.2 France 麻豆原创 Digital Pathology Services Forecast
10.4.3 UK 麻豆原创 Digital Pathology Services Forecast
10.4.4 Italy 麻豆原创 Digital Pathology Services Forecast
10.4.5 Russia 麻豆原创 Digital Pathology Services Forecast
10.5 Middle East & Africa Digital Pathology Services Forecast by Region (2025-2030)
10.5.1 Egypt 麻豆原创 Digital Pathology Services Forecast
10.5.2 South Africa 麻豆原创 Digital Pathology Services Forecast
10.5.3 Israel 麻豆原创 Digital Pathology Services Forecast
10.5.4 Turkey 麻豆原创 Digital Pathology Services Forecast
10.6 Global Digital Pathology Services Forecast by Type (2025-2030)
10.7 Global Digital Pathology Services Forecast by Application (2025-2030)
10.7.1 GCC Countries 麻豆原创 Digital Pathology Services Forecast
11 Key Players Analysis
11.1 Inotiv
11.1.1 Inotiv Company Information
11.1.2 Inotiv Digital Pathology Services Product Offered
11.1.3 Inotiv Digital Pathology Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.1.4 Inotiv Main Business Overview
11.1.5 Inotiv Latest Developments
11.2 Charles River Laboratories
11.2.1 Charles River Laboratories Company Information
11.2.2 Charles River Laboratories Digital Pathology Services Product Offered
11.2.3 Charles River Laboratories Digital Pathology Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.2.4 Charles River Laboratories Main Business Overview
11.2.5 Charles River Laboratories Latest Developments
11.3 Leica Biosystems
11.3.1 Leica Biosystems Company Information
11.3.2 Leica Biosystems Digital Pathology Services Product Offered
11.3.3 Leica Biosystems Digital Pathology Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.3.4 Leica Biosystems Main Business Overview
11.3.5 Leica Biosystems Latest Developments
11.4 Olympus
11.4.1 Olympus Company Information
11.4.2 Olympus Digital Pathology Services Product Offered
11.4.3 Olympus Digital Pathology Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.4.4 Olympus Main Business Overview
11.4.5 Olympus Latest Developments
11.5 Philips
11.5.1 Philips Company Information
11.5.2 Philips Digital Pathology Services Product Offered
11.5.3 Philips Digital Pathology Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.5.4 Philips Main Business Overview
11.5.5 Philips Latest Developments
11.6 Roche
11.6.1 Roche Company Information
11.6.2 Roche Digital Pathology Services Product Offered
11.6.3 Roche Digital Pathology Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.6.4 Roche Main Business Overview
11.6.5 Roche Latest Developments
11.7 Hamamatsu Photonics
11.7.1 Hamamatsu Photonics Company Information
11.7.2 Hamamatsu Photonics Digital Pathology Services Product Offered
11.7.3 Hamamatsu Photonics Digital Pathology Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.7.4 Hamamatsu Photonics Main Business Overview
11.7.5 Hamamatsu Photonics Latest Developments
11.8 ZEISS
11.8.1 ZEISS Company Information
11.8.2 ZEISS Digital Pathology Services Product Offered
11.8.3 ZEISS Digital Pathology Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.8.4 ZEISS Main Business Overview
11.8.5 ZEISS Latest Developments
11.9 OptraScan
11.9.1 OptraScan Company Information
11.9.2 OptraScan Digital Pathology Services Product Offered
11.9.3 OptraScan Digital Pathology Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.9.4 OptraScan Main Business Overview
11.9.5 OptraScan Latest Developments
11.10 Media Cyber鈥嬧€媙etics
11.10.1 Media Cyber鈥嬧€媙etics Company Information
11.10.2 Media Cyber鈥嬧€媙etics Digital Pathology Services Product Offered
11.10.3 Media Cyber鈥嬧€媙etics Digital Pathology Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.10.4 Media Cyber鈥嬧€媙etics Main Business Overview
11.10.5 Media Cyber鈥嬧€媙etics Latest Developments
11.11 Visiopharm
11.11.1 Visiopharm Company Information
11.11.2 Visiopharm Digital Pathology Services Product Offered
11.11.3 Visiopharm Digital Pathology Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.11.4 Visiopharm Main Business Overview
11.11.5 Visiopharm Latest Developments
11.12 Sectra
11.12.1 Sectra Company Information
11.12.2 Sectra Digital Pathology Services Product Offered
11.12.3 Sectra Digital Pathology Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.12.4 Sectra Main Business Overview
11.12.5 Sectra Latest Developments
11.13 Digital Slide Archive
11.13.1 Digital Slide Archive Company Information
11.13.2 Digital Slide Archive Digital Pathology Services Product Offered
11.13.3 Digital Slide Archive Digital Pathology Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.13.4 Digital Slide Archive Main Business Overview
11.13.5 Digital Slide Archive Latest Developments
11.14 Aiforia
11.14.1 Aiforia Company Information
11.14.2 Aiforia Digital Pathology Services Product Offered
11.14.3 Aiforia Digital Pathology Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.14.4 Aiforia Main Business Overview
11.14.5 Aiforia Latest Developments
11.15 PathAI
11.15.1 PathAI Company Information
11.15.2 PathAI Digital Pathology Services Product Offered
11.15.3 PathAI Digital Pathology Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.15.4 PathAI Main Business Overview
11.15.5 PathAI Latest Developments
11.16 Pathomation
11.16.1 Pathomation Company Information
11.16.2 Pathomation Digital Pathology Services Product Offered
11.16.3 Pathomation Digital Pathology Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.16.4 Pathomation Main Business Overview
11.16.5 Pathomation Latest Developments
11.17 Proscia
11.17.1 Proscia Company Information
11.17.2 Proscia Digital Pathology Services Product Offered
11.17.3 Proscia Digital Pathology Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.17.4 Proscia Main Business Overview
11.17.5 Proscia Latest Developments
11.18 Indica Labs
11.18.1 Indica Labs Company Information
11.18.2 Indica Labs Digital Pathology Services Product Offered
11.18.3 Indica Labs Digital Pathology Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.18.4 Indica Labs Main Business Overview
11.18.5 Indica Labs Latest Developments
11.19 Gestalt
11.19.1 Gestalt Company Information
11.19.2 Gestalt Digital Pathology Services Product Offered
11.19.3 Gestalt Digital Pathology Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.19.4 Gestalt Main Business Overview
11.19.5 Gestalt Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.